Dr. Larisa J Geskin, MD
Claim this profileColumbia University Pediatric Neuromuscular Center Columbia UMC
Studies Cutaneous T-Cell Lymphoma
Studies Fungal Infection
5 reported clinical trials
7 drugs studied
Area of expertise
1Cutaneous T-Cell Lymphoma
Stage I
Stage II
Stage IV
2Fungal Infection
Stage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Larisa J Geskin, MD is currently running
Photopheresis
for Mycosis Fungoides
The purpose of this study is to determine whether photopheresis therapy can be used to improve the clinical course of early stage cutaneous T-cell lymphoma (CTCL). Currently, photopheresis is performed as a palliative treatment for late stage CTCL. However, recent studies have demonstrated that patients with early stage CTCL may have markers in their blood which were previously observed primarily in late stage disease, such as clonal T cell populations. Considering these findings, the study aims to investigate whether photopheresis therapy may be used earlier in the disease course to produce a clinical response.
Recruiting1 award Phase 29 criteria
StrataCTX® Gel
for Skin Reactions from Cancer Treatment
This trial is testing StrataCTX® to see if it can reduce the need for steroids in treating skin reactions in people with certain cancers. The goal is to find a safer alternative to steroids, which have many side effects. StrataCTX® might help manage these skin issues more effectively. StrataXRT® is a silicone-based gel used for preventing and managing skin problems caused by radiation.
Recruiting1 award N/A
More about Larisa J Geskin, MD
Clinical Trial Related5 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Larisa J Geskin, MD has experience with
- Pembrolizumab
- Gemcitabine
- IPH4102
- UVADEX® (methoxsalen) Sterile Solution
- THERAKOS® CELLEX Photopheresis System
- StrataCTX® Gel
Breakdown of trials Larisa J Geskin, MD has run
Cutaneous T-Cell Lymphoma
Fungal Infection
Mycosis Fungoides
Sezary Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Larisa J Geskin, MD specialize in?
Larisa J Geskin, MD focuses on Cutaneous T-Cell Lymphoma and Fungal Infection. In particular, much of their work with Cutaneous T-Cell Lymphoma has involved Stage I patients, or patients who are Stage II.
Is Larisa J Geskin, MD currently recruiting for clinical trials?
Yes, Larisa J Geskin, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Larisa J Geskin, MD has studied deeply?
Yes, Larisa J Geskin, MD has studied treatments such as Pembrolizumab, Gemcitabine, IPH4102.
What is the best way to schedule an appointment with Larisa J Geskin, MD?
Apply for one of the trials that Larisa J Geskin, MD is conducting.
What is the office address of Larisa J Geskin, MD?
The office of Larisa J Geskin, MD is located at: Columbia University Pediatric Neuromuscular Center Columbia UMC, New York, New York 10032 United States. This is the address for their practice at the Columbia University Pediatric Neuromuscular Center Columbia UMC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.